MindImmune Therapeutics closes $500K seed round led by Slater Fund

MINDIMMUNE THERAPEUTICS is a South Kingstown-based pharmaceutical startup. Above, the MindImmune Therapeutics lab at the University of Rhode Island. /COURTESY MINDIMMUNE THERAPEUTICS
MINDIMMUNE THERAPEUTICS is a South Kingstown-based pharmaceutical startup. Commerce RI awarded the company a $50,000 Innovation Voucher grant to partner with the University of Rhode Island and establish animal models of brain immune system dysfunction, as a means to screen for new Alzheimer’s disease therapies. Above, the MindImmune Therapeutics lab at the University of Rhode Island. /COURTESY MINDIMMUNE THERAPEUTICS
PROVIDENCE – MindImmune Therapeutics Inc., a pharmaceutical startup, closed its second seed round of $500,000 on Monday. The round was led by a $250,000 investment from Slater Technology Fund, a publicly funded venture capital firm in Providence. MindImmune, based out of the University of Rhode Island, is developing drugs to target the immune system as…
To read the full story, Subscribe or
Subscribe to PBN
- Advertisement -